Suchergebnisse
Target Corp.
WKN: 856243 / Symbol: TGT / Name: Target / Aktie / Einzelhandel / Large Cap /
Targeted Microwave Solutions Inc
WKN: A2ACNT / Name: Targeted MWS / Aktie / Kommerzielle Dienstleistungen / Micro Cap /
Lyell Immunopharma Targets 2027 FDA Filing as CAR-T Pipeline Advances
Key Points
- Interested in Lyell Immunopharma, Inc.? Here are five stocks we like better.
- Lyell Immunopharma is targeting a 2027 FDA filing for ronde-cel, its lead CAR-T therapy in large B-cell
Black Rock Coffee Bar Targets 1,000 Stores as Loyalty Fuels Growth Plan
Key Points
- Interested in Black Rock Coffee Bar, Inc.? Here are five stocks we like better.
- Black Rock Coffee Bar said it is targeting 1,000 stores by 2035, with management aiming for about 20%
Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Key Points
- Interested in Walmart Inc.? Here are five stocks we like better.
- Despite all three posting solid results, TJX Companies rose 5.6% after earnings, while Walmart fell 7.3% and Target
Is Most-Watched Stock Target Corporation (TGT) Worth Betting on Now?
Target (TGT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of
Is Target Finally Winning Back Shoppers Across Key Categories?
Target Corporation’s TGT first-quarter fiscal 2026 results offered a clear answer to one of the key questions around the business. Are shoppers responding to the company’s primary product
Is Trending Stock Target Corporation (TGT) a Buy Now?
Target (TGT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Shares of
Northrop Grumman Secures Navy Contract for GQM-163A Target Support
Northrop Grumman Corporation NOC has recently secured a $100 million contract from the U.S. Navy to support the production and launch operations of the GQM-163A aerial target missile system. The
GlobalFoundries Eyes AI, Data Center Growth as It Targets 40% Margins
Key Points
- Interested in GlobalFoundries Inc.? Here are five stocks we like better.
- GlobalFoundries said it is positioning itself for growth in AI, data centers, silicon photonics, and custom
InterDigital Eyes $1B ARR by 2030 as 6G, AI Video and Patent Push Take Center Stage
Key Points
- Interested in InterDigital, Inc.? Here are five stocks we like better.
- InterDigital is targeting more than $1 billion in annual recurring revenue by 2030, up from about $560 million
The Careful Consumer: What Q1 Earnings Reveal—And Where Cracks May Appear
Key Points
- Interested in Target Corporation? Here are five stocks we like better.
- Walmart, Home Depot, and other retailers say consumers remain active but increasingly price-sensitive.
Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet
Nuvectis Pharma, Inc. (NVCT) closed the last trading session at $10.35, gaining 16.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Can Willdan (WLDN) Climb 38.96% to Reach the Level Wall Street Analysts Expect?
Willdan Group (WLDN) closed the last trading session at $93.55, gaining 20% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe Atlassian (TEAM) Could Rally 49.75%: Here's is How to Trade
Atlassian (TEAM) closed the last trading session at $85.42, gaining 19.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts See a 30.54% Upside in Viavi Solutions (VIAV): Can the Stock Really Move This High?
Viavi Solutions (VIAV) closed the last trading session at $49.51, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade
Biodesix, Inc. (BDSX) closed the last trading session at $14.93, gaining 40.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall